TechConnect Innovation Program

A New Biomaterial, Beta-glucan Hydrogel Scaffold

Quegen Biotech, California, United States

TECHNOLOGY SUMMARY

Our patented technology is a new biopolymer scaffold which can be used as base materials for Stem Cell Support, Matrix for Artificial Skin, Scaffold for Biomaterial, Scar, Burn Treatment, Immunity Modulator, Skin Regeneration, Filler for Wrinkle, Breast

Primary Application Area: Medical Devices

Technology Development Status: Ready to Market

Technology Readiness Level: TRL 9

FIGURES OF MERIT

Value Proposition: Beta-Glucan Scaffold USA PCT Patent Registered:
Patent Title : Production of new biomaterial based on beta-glucan using Radiation Fusion Technology (2013.11.23 registered)
Previous scaffolds use toxic chemicals/agents to cross-link polymers. But our scaffold does not use toxic chemicals/agents. It is safe and long lasting.

SHOWCASE SUMMARY

Organization Type: Corporation

National Innovation Awardee

Showcase Booth #: 110

Website: www.quegen.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date:

Primary Sources of Funding: Venture Capital

Looking for: Both Funding and Development Partners